Pharming Group's total assets for Q1 2026 were €488.86M, a decrease of -2.23% from the previous quarter. NL:PHARM total liabilities were €220.18M for the fiscal quarter, a -1.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.